OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
64
Results
Show all
Save search
Copy query
Show results for
Unknown
(63)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Colon
(1)
Disease
Colon cancer
(1)
Technology Type
Mass Spectrometry
(1)
SWATH MS
(1)
Publication Date
2019
(1)
Release Date
2025
(10)
2022
(8)
2024
(7)
2023
(6)
2021
(5)
2019
(5)
2017
(5)
2014
(5)
2018
(3)
2016
(3)
2015
(3)
2020
(2)
2011
(1)
Lab affiliation
Medical Oncology Department, Reina Sofia University Hospital and IMIBIC, Maimonides Institute for Biomedical Research, Córdoba, Spain
(1)
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
Not available
S-EPMC6934456
|
biostudies-literature
Cite
Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea.
Not available
S-EPMC10273112
|
biostudies-literature
Cite
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
Not available
S-EPMC7531795
|
biostudies-literature
Cite
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.
Not available
S-EPMC10102835
|
biostudies-literature
Cite
The role of CDK4/6 inhibitors in early breast cancer.
Not available
S-EPMC8184648
|
biostudies-literature
Cite
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.
Not available
S-EPMC4319639
|
biostudies-literature
Cite
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
Not available
S-EPMC9208076
|
biostudies-literature
Cite
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Not available
S-EPMC11249439
|
biostudies-literature
Cite
Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain.
Not available
S-EPMC5700215
|
biostudies-literature
Cite
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Not available
S-EPMC4746087
|
biostudies-literature
Cite
Previous
page
1 / 7
You're on page
1
page
2
page
3
page
4
page
5
page
6
page
7
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
